Trials / Completed

CompletedNCT00527514

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

A Prospective, Open-label Study to Assess the Efficacy and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Subjects With Stage 1 and Stage 2 Hypertension

Status: Completed
Phase: Phase 3
Study type: Interventional
Enrollment: 185 (actual)

Sponsor: Daiichi Sankyo · Industry
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This study will be conducted to assess the efficacy and safety of an amlodipine/olmesartan treatment regimen in stage 1 and stage 2 hypertensive subjects.

Conditions

Hypertension

Interventions

Type	Name	Description
DRUG	Amlodipine	Tablets
DRUG	Olmesartan medoxomil plus amlodipine	Tablets

Timeline

Start date: 2007-09-01
Primary completion: 2008-04-01
Completion: 2008-04-01
First posted: 2007-09-11
Last updated: 2009-11-11
Results posted: 2009-09-23

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00527514. Inclusion in this directory is not an endorsement.